2018 Earnings Reports Reach New Highs with #Cannabis
and #CBD Market; (OTCQB: $NLBS) (OTCQX: $CWBHF) (NASDAQ: $VFF) (NYSE: $APHA)
Point Roberts, WA and Delta, BC - April 9, 2019
(Investorideas.com Newswire) Investorideas.com, a leading investor news resource
covering hemp and cannabis stocks releases a market snapshot discussing how the
recent influx of positive 2018 financials have helped embolden the CBD market
and showcase its progress in spite of unclear government regulations.
As discussed in a recent Forbes article “the two biggest pharmacy chains in the
United States decided that CBD was worth exploring. Both CVS and Walgreens announced – within days of each other – that they
would begin selling hemp-derived CBD products in 2,300 stores between the two
nationwide chains. While you won’t find the trendy CBD products listed at these
drugstores, their shelves will soon contain a variety of topical applications
like creams, lotions, salves, patches, and sprays.”
Continued: “The fact
that nationally recognized brands are putting their weight behind
cannabis-tangential products is almost certainly a harbinger of things to come
– even if the complex reality of FDA regulations forces the drugstore chains to
limit their CBD product lines to topical applications for practical and legal
reasons.”
This endorsement of
the CBD sector is only emboldened further with the recent string of positive
2018 financials coming out
NutraLife Biosciences, Inc. (OTCQB: NLBS), a company that develops, manufactures, and distributes
nutraceutical, wellness, and CBD products, under the NutraHempCBD brand and
oral spray vitamins and supplements under the NutraSpray brand, recently
announced revenue growth of approximately 107.3% in 2018, the filing of its
Annual Report on Form 10-K and audited financial results. Some of the highlights from the Company’s financial
results reported in its Form 10-K for the year ended December 31, 2018 include:
increased sales to $3,711,327 for the year ended December 31, 2018 compared to
$1,790,168 for the year ended December 31, 2017, an increase of approximately
107.3%, cost of sales was $2,211,039 compared to $1,055,042 for the years ended
December 31, 2018 and 2017, respectively, or a 109.6% increase, gross margin
for the year ended December 31, 2018 was $1,500,288, a 104.1% increase over the
year ended December 31, 2017 and sales of CBD products increased from
approximately $1,380,000 for the year ended December 31, 2017 to $2,400,000 for
the year ended December 31, 2018 representing 77% and 78% of our revenues for
such periods.
Edgar Ward, Founder and Chief Executive Officer of
NutraLife Biosciences recently commented on the CVS CBD news, saying “It is
encouraging to see that mainstream retail giants like CVS are offering hemp
derived CBD products to consumers.”
Charlotte's
Web Holdings Inc. (CSE: CWEB) (OTCQX: CWBHF), the market share leader in hemp-derived CBD extract
products, recently reported financial results for the fourth quarter
and year ended December 31, 2018. Some of the highlights of Fourth Quarter 2018
Results versus Fourth Quarter 2017 Results were: an organic consolidated
revenue growth of 71% to $21.5 million (up 21% QoQ), gross profit increased 63%
to $16.3 million, or 76% of consolidated revenue, adjusted EBITDA decreased
from 37% to 20% of consolidated revenue, due to extraordinary items and 57% of
revenue from eCommerce.
Village Farms International, Inc. (TSX: VFF) (NASDAQ: VFF) just recently announced its financial results for the fourth quarter
and year ended December 31, 2018.
Some of the financial
and corporate highlights for the Fourth Quarter Ended December 31, 2018
included: a net income improved of US$0.3 million, or US$0.01 per share, sales,
including the Company's proportionate share of Pure Sunfarms' sales, increased
to US$40.6 million compared with US$36.9 million, EBITDA, was US$1.5 million
compared with US$2.6 million. EBITDA included $0.9 million from Pure Sunfarms
and the Company's common shares commenced trading on the Nasdaq Capital Market
under the symbol "VFF".
While most eyes are currently on the US CBD market, Aphria Inc. (TSX: APHA) (NYSE: APHA) through its subsidiary Aphria
Deutschland GmbH is focusing on other markets having recently launched the Company's first CBD-based
nutraceutical, the first product in its CBD-based cosmetics line for the German
market. Featuring CBD derived from hemp, the CannRelief brand of products are
being produced in the European Union and distributed by the Company's
subsidiary, CC Pharma, which has access to more than
13,000 pharmacies throughout Germany.
Before we see more
major chains really double down on the cannabis landscape, a new regulatory
framework will have to be developed and implemented, providing guidance for
what these companies can and can’t do. Though we may be a long way off from
that framework coming into place, a continued string of positive financials and
interest from large parties like this is encouraging to see and helps give
credence to the industry.
For investors
following cannabis stocks, Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana/Hemp Stocks
About Investorideas.com
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and
Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI Eye
Podcast and column covering developments in AI.
Follow us on Cannabis Social Media
Disclaimer/Disclosure:.
Our site does not make recommendations for purchases or sale of stocks, services
or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investment involves
risk and possible loss of investment. This site is currently compensated for
news publication and distribution, social media and marketing, content creation
and more. Contact each company directly regarding content and press release
questions. Disclosure is posted for each compensated news release, content
published /created if required but otherwise the news was not compensated for
and was published for the sole interest of our readers and followers. More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this article featuring
NutraLife Biosciences Inc. (OTC: NLBS) is a paid for service on Investorideas.com (
third party). Learn more about costs and our services https://www.investorideas.com/News-Upload/
Global investors must
adhere to regulations of each country.
Investor Ideas does not condone the use of cannabis
except where permissible by law. Our site does not possess, distribute, or sell
cannabis products.
Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment